Orion Oyj

HEL:ORNBV.HE

36.65 (EUR) • At close November 27, 2023
Bedrijfsnaam Orion Oyj
Symbool ORNBV.HE
Munteenheid EUR
Prijs 37.63
Beurswaarde 5,281,746,499
Dividendpercentage 2.15%
52-weken bereik 32.89 - 55.16
Industrie Drug Manufacturers—General
Sector Healthcare
CEO Dr. Liisa Hurme
Website https://www.orion.fi

An error occurred while fetching data.

Over Orion Oyj

Orion Oyj develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, other European countries, North America, and internationally. It provides prescription drugs and self-care products, including Nubeqa for the treatment of prostate cancer; dexdor and Precedex for intensive care sedative; Stalevo and Comtess/Comtan

Vergelijkbare Aandelen

Terveystalo Oyj logo

Terveystalo Oyj

TTALO.HE

7.12 EUR

Revenio Group Oyj logo

Revenio Group Oyj

REG1V.HE

24.12 EUR

Oriola Oyj logo

Oriola Oyj

OKDBV.HE

1.044 EUR

Nanoform Finland Oyj logo

Nanoform Finland Oyj

NANOFH.HE

1.68 EUR

Pihlajalinna Oyj logo

Pihlajalinna Oyj

PIHLIS.HE

7.75 EUR

Modulight Oyj logo

Modulight Oyj

MODU.HE

1.218 EUR

Optomed Oyj logo

Optomed Oyj

OPTOMED.HE

3.16 EUR

Nexstim Plc logo

Nexstim Plc

NXTMH.HE

2.4 EUR

Biohit Oyj logo

Biohit Oyj

BIOBV.HE

1.95 EUR

Herantis Pharma Oyj logo

Herantis Pharma Oyj

HRTIS.HE

1.69 EUR

Financiële Gegevens

Cijfers zijn in miljoenen (EUR)

Cijfers zijn in miljoenen (EUR)